Biotech firm ReViral, with HQ in Durham, raises $44M in Series C funding
The round was led by CR-CP Life Science Fund. Additional investors included Andera Partners, Brace Pharma Capital, Green Sands Equity, New Leaf Venture Partners, Novo Holdings, OrbiMed Advisors, and Perceptive Advisors.
Read More
